trending Market Intelligence /marketintelligence/en/news-insights/trending/8kbhnodan_ddfkher_67rg2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Clementia Pharmaceuticals names board member


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Clementia Pharmaceuticals names board member

Montreal-based Clementia Pharmaceuticals Inc. appointed Shawn Tomasello to its board.

Tomasello was most recently chief commercial officer of Kite Pharma Inc.

Meanwhile, Jean-François Pariseau, who has served on the company's board since 2012, stepped down, effective immediately.

Clementia develops treatments for ultra-rare bone disorders and other diseases with high medical need.